
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study
Naoyoshi Nagata, Suguru Nishijima, Yasushi Kojima, et al.
Gastroenterology (2022) Vol. 163, Iss. 1, pp. 222-238
Open Access | Times Cited: 119
Naoyoshi Nagata, Suguru Nishijima, Yasushi Kojima, et al.
Gastroenterology (2022) Vol. 163, Iss. 1, pp. 222-238
Open Access | Times Cited: 119
Showing 1-25 of 119 citing articles:
Population-level Metagenomics Uncovers Distinct Effects of Multiple Medications on the Human Gut Microbiome
Naoyoshi Nagata, Suguru Nishijima, Tohru Miyoshi‐Akiyama, et al.
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 1038-1052
Open Access | Times Cited: 97
Naoyoshi Nagata, Suguru Nishijima, Tohru Miyoshi‐Akiyama, et al.
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 1038-1052
Open Access | Times Cited: 97
Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications
Naoyoshi Nagata, Tadashi Takeuchi, Hiroaki Masuoka, et al.
Gastroenterology (2022) Vol. 164, Iss. 2, pp. 272-288
Open Access | Times Cited: 97
Naoyoshi Nagata, Tadashi Takeuchi, Hiroaki Masuoka, et al.
Gastroenterology (2022) Vol. 164, Iss. 2, pp. 272-288
Open Access | Times Cited: 97
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 69
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 69
A core microbiome signature as an indicator of health
Guojun Wu, Ting Xu, Naisi Zhao, et al.
Cell (2024) Vol. 187, Iss. 23, pp. 6550-6565.e11
Open Access | Times Cited: 30
Guojun Wu, Ting Xu, Naisi Zhao, et al.
Cell (2024) Vol. 187, Iss. 23, pp. 6550-6565.e11
Open Access | Times Cited: 30
Microbiome as a biomarker and therapeutic target in pancreatic cancer
Ghazaleh Pourali, Danial Kazemi, Amir Shayan Chadeganipour, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 22
Ghazaleh Pourali, Danial Kazemi, Amir Shayan Chadeganipour, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 22
Roles of microbiota in pancreatic cancer development and treatment
Mariana Santos Cruz, Joseph Tintelnot, Nicola Gagliani
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 21
Mariana Santos Cruz, Joseph Tintelnot, Nicola Gagliani
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 21
Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science
Kentaro Inamura, Tsuyoshi Hamada, Susan Bullman, et al.
Gut (2022) Vol. 71, Iss. 10, pp. 2107-2122
Open Access | Times Cited: 53
Kentaro Inamura, Tsuyoshi Hamada, Susan Bullman, et al.
Gut (2022) Vol. 71, Iss. 10, pp. 2107-2122
Open Access | Times Cited: 53
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection
Hongliang Tian, Jiaqu Cui, Chen Ye, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 28
Hongliang Tian, Jiaqu Cui, Chen Ye, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 28
Multi-kingdom microbial signatures in excess body weight colorectal cancer based on global metagenomic analysis
Xinyue Zhu, Pingping Xu, Ruixin Zhu, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 10
Xinyue Zhu, Pingping Xu, Ruixin Zhu, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 10
Comparison between 16S rRNA and shotgun sequencing in colorectal cancer, advanced colorectal lesions, and healthy human gut microbiota
David Bars‐Cortina, Elies Ramon, Blanca Rius‐Sansalvador, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 10
David Bars‐Cortina, Elies Ramon, Blanca Rius‐Sansalvador, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 10
An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome
Shuaiming Jiang, Wenyao Ma, Chenchen Ma, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Shuaiming Jiang, Wenyao Ma, Chenchen Ma, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Barriers and opportunities in pancreatic cancer immunotherapy
Yixin Ju, Dongzhi Xu, Miao-Miao Liao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Yixin Ju, Dongzhi Xu, Miao-Miao Liao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations
Suguru Nishijima, Evelina Stankevič, Oliver Aasmets, et al.
Cell (2024)
Open Access | Times Cited: 9
Suguru Nishijima, Evelina Stankevič, Oliver Aasmets, et al.
Cell (2024)
Open Access | Times Cited: 9
Microbiome and pancreatic cancer: time to think about chemotherapy
Juliana de Castilhos, Katharina Tillmanns, J. A. BLESSING, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Juliana de Castilhos, Katharina Tillmanns, J. A. BLESSING, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Dysbiosis–NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes
Sara Fanijavadi, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 730-730
Open Access | Times Cited: 1
Sara Fanijavadi, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 730-730
Open Access | Times Cited: 1
Biomarkers, Omics and Artificial Intelligence for Early Detection of Pancreatic Cancer.
Kate Murray, Lucy Oldfield, Irena Stefanova, et al.
Seminars in Cancer Biology (2025) Vol. 111, pp. 76-88
Closed Access | Times Cited: 1
Kate Murray, Lucy Oldfield, Irena Stefanova, et al.
Seminars in Cancer Biology (2025) Vol. 111, pp. 76-88
Closed Access | Times Cited: 1
Regulatory effects of oral microbe on intestinal microbiota and the illness
Yanbei Lu, Zhengyi Li, Xian Peng
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 21
Yanbei Lu, Zhengyi Li, Xian Peng
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 21
Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets
Jia‐Hao Dai, Xi-Rong Tan, Han Qiao, et al.
Protein & Cell (2023) Vol. 15, Iss. 4, pp. 239-260
Open Access | Times Cited: 19
Jia‐Hao Dai, Xi-Rong Tan, Han Qiao, et al.
Protein & Cell (2023) Vol. 15, Iss. 4, pp. 239-260
Open Access | Times Cited: 19
Performance of Gut Microbiome as an Independent Diagnostic Tool for 20 Diseases: Cross-Cohort Validation of Machine-Learning Classifiers
Min Li, Jinxin Liu, Jiaying Zhu, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Min Li, Jinxin Liu, Jiaying Zhu, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Association between Residential Greenness and Human Microbiota: Evidence from Multiple Countries
Yidan Zhang, Shujun Fan, Zheng Zhang, et al.
Environmental Health Perspectives (2023) Vol. 131, Iss. 8
Open Access | Times Cited: 17
Yidan Zhang, Shujun Fan, Zheng Zhang, et al.
Environmental Health Perspectives (2023) Vol. 131, Iss. 8
Open Access | Times Cited: 17
Dysbiosis Signature of Fecal Microbiota in Patients with Pancreatic Adenocarcinoma and Pancreatic Intraductal Papillary Mucinous Neoplasms
Theodoros Sidiropoulos, Nikolas Dovrolis, Hector Katifelis, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1040-1040
Open Access | Times Cited: 7
Theodoros Sidiropoulos, Nikolas Dovrolis, Hector Katifelis, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1040-1040
Open Access | Times Cited: 7
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 7
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 7
Predicting Personalized Responses to Dietary Fiber Interventions: Opportunities for Modulation of the Gut Microbiome to Improve Health
Car Reen Kok, Devin J. Rose, Robert W. Hutkins
Annual Review of Food Science and Technology (2022) Vol. 14, Iss. 1, pp. 157-182
Open Access | Times Cited: 24
Car Reen Kok, Devin J. Rose, Robert W. Hutkins
Annual Review of Food Science and Technology (2022) Vol. 14, Iss. 1, pp. 157-182
Open Access | Times Cited: 24
The Role of the Microbiome in Pancreatic Cancer
Koji Miyabayashi, Hideaki Ijichi, Mitsuhiro Fujishiro
Cancers (2022) Vol. 14, Iss. 18, pp. 4479-4479
Open Access | Times Cited: 23
Koji Miyabayashi, Hideaki Ijichi, Mitsuhiro Fujishiro
Cancers (2022) Vol. 14, Iss. 18, pp. 4479-4479
Open Access | Times Cited: 23
Oral Microbiota: The Influences and Interactions of Saliva, IgA, and Dietary Factors in Health and Disease
Daisuke Nagakubo, Yuichiro Kaibori
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2307-2307
Open Access | Times Cited: 15
Daisuke Nagakubo, Yuichiro Kaibori
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2307-2307
Open Access | Times Cited: 15